交易 Black Diamond Therapeutics, Inc. - BDTX CFD
加入收藏夹- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
价差 | 0.0270 | ||||||||
多头隔夜费
多头隔夜费
前往平台 | -0.026179% | ||||||||
空头隔夜费
空头隔夜费
前往平台 | 0.003957% | ||||||||
隔夜费时间 | 22:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Black Diamond Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Mar 15, 2024 | 4.7715 | 0.2100 | 4.60% | 4.5615 | 5.0015 | 4.4915 |
Mar 14, 2024 | 4.5115 | 0.3200 | 7.63% | 4.1915 | 4.6315 | 4.1415 |
Mar 13, 2024 | 4.1815 | 0.4100 | 10.87% | 3.7715 | 4.2515 | 3.6915 |
Mar 12, 2024 | 3.7615 | -0.1800 | -4.57% | 3.9415 | 3.9815 | 3.6915 |
Mar 11, 2024 | 3.9815 | -0.0300 | -0.75% | 4.0115 | 4.1715 | 3.9515 |
Mar 8, 2024 | 4.0615 | -0.1000 | -2.40% | 4.1615 | 4.4215 | 4.0415 |
Mar 7, 2024 | 4.1815 | -0.1800 | -4.13% | 4.3615 | 4.5515 | 4.1515 |
Mar 6, 2024 | 4.4115 | 0.1000 | 2.32% | 4.3115 | 4.5215 | 4.3115 |
Mar 5, 2024 | 4.3915 | 0.0300 | 0.69% | 4.3615 | 4.4815 | 4.3015 |
Mar 4, 2024 | 4.4915 | -0.3100 | -6.46% | 4.8015 | 4.8515 | 4.4515 |
Mar 1, 2024 | 4.7615 | -0.3700 | -7.21% | 5.1315 | 5.3215 | 4.6515 |
Feb 29, 2024 | 5.1315 | -0.0100 | -0.19% | 5.1415 | 5.2515 | 4.9515 |
Feb 28, 2024 | 4.9315 | 0.0900 | 1.86% | 4.8415 | 5.5615 | 4.8015 |
Feb 27, 2024 | 4.8815 | -0.0100 | -0.20% | 4.8915 | 5.0515 | 4.7915 |
Feb 26, 2024 | 4.8715 | 0.1900 | 4.06% | 4.6815 | 4.9815 | 4.6815 |
Feb 23, 2024 | 4.6815 | 0.2500 | 5.64% | 4.4315 | 4.7515 | 4.4215 |
Feb 22, 2024 | 4.4815 | -0.0900 | -1.97% | 4.5715 | 4.7615 | 4.4415 |
Feb 21, 2024 | 4.6615 | -0.1000 | -2.10% | 4.7615 | 4.9215 | 4.5415 |
Feb 20, 2024 | 4.8515 | -0.3000 | -5.82% | 5.1515 | 5.6315 | 4.6315 |
Feb 16, 2024 | 5.3315 | 0.3300 | 6.60% | 5.0015 | 5.5615 | 4.8515 |
Black Diamond Therapeutics, Inc. Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
Tuesday, May 7, 2024 | ||
时间(协调世界时) (UTC) 12:30 | 国家 US
| 事件 Q1 2024 Black Diamond Therapeutics Inc Earnings Release Q1 2024 Black Diamond Therapeutics Inc Earnings ReleaseForecast(预报) -上一页 - |
Wednesday, May 15, 2024 | ||
时间(协调世界时) (UTC) 13:00 | 国家 US
| 事件 Black Diamond Therapeutics Inc Annual Shareholders Meeting Black Diamond Therapeutics Inc Annual Shareholders MeetingForecast(预报) -上一页 - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 92.828 | 126.872 | 69.57 | 29.332 | 8.904 |
銷售/一般/行政費用,總計 | 28.391 | 30.043 | 21.361 | 7.579 | 1.954 |
研究與開發 | 64.437 | 96.829 | 48.209 | 21.753 | 6.95 |
異常費用(收入) | 0 | ||||
營業收入 | -92.828 | -126.872 | -69.57 | -29.332 | -8.904 |
利息收入(費用),非經營淨值 | -0.219 | 3.464 | 4.041 | -5.932 | -0.011 |
其他,淨值 | -0.354 | -2.188 | -1.725 | 0.006 | -0.016 |
稅前淨收入 | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
稅後淨收入 | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
未計算非常項目前的淨收益 | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
淨收入 | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
普通股股東可獲收益 (不含非經常性項目) | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
普通股股東可獲收益 (含非經常性項目) | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
攤薄淨收入 | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
攤薄後加權平均股 | 36.3256 | 36.189 | 32.9071 | 32.6364 | 32.6364 |
扣除特別項目的每股攤薄盈利 | -2.50977 | -3.47056 | -2.04375 | -1.08033 | -0.27365 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
每股正常攤薄盈利 | -2.57122 | -3.47056 | -2.04375 | -1.08033 | -0.27365 |
Gain (Loss) on Sale of Assets | 2.232 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 20.032 | 21.561 | 21.852 | 22.124 | 23.173 |
銷售/一般/行政費用,總計 | 6.878 | 6.808 | 7.243 | 6.277 | 6.978 |
研究與開發 | 13.154 | 14.753 | 14.609 | 15.847 | 16.195 |
營業收入 | -20.032 | -21.561 | -21.852 | -22.124 | -23.173 |
利息收入(費用),非經營淨值 | 0.539 | 0.622 | -1.573 | 0.562 | 0.386 |
其他,淨值 | 0.341 | 0.064 | 0.115 | -0.092 | -0.143 |
稅前淨收入 | -19.152 | -20.875 | -21.078 | -21.654 | -22.93 |
稅後淨收入 | -19.152 | -20.875 | -21.078 | -21.654 | -22.93 |
未計算非常項目前的淨收益 | -19.152 | -20.875 | -21.078 | -21.654 | -22.93 |
淨收入 | -19.152 | -20.875 | -21.078 | -21.654 | -22.93 |
普通股股東可獲收益 (不含非經常性項目) | -19.152 | -20.875 | -21.078 | -21.654 | -22.93 |
普通股股東可獲收益 (含非經常性項目) | -19.152 | -20.875 | -21.078 | -21.654 | -22.93 |
攤薄淨收入 | -19.152 | -20.875 | -21.078 | -21.654 | -22.93 |
攤薄後加權平均股 | 36.5161 | 36.4839 | 36.3902 | 36.3462 | 36.2939 |
扣除特別項目的每股攤薄盈利 | -0.52448 | -0.57217 | -0.57922 | -0.59577 | -0.63179 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.52448 | -0.57217 | -0.64056 | -0.59577 | -0.63179 |
Gain (Loss) on Sale of Assets | 2.232 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 127.706 | 215.703 | 319.554 | 155.714 | 51.684 |
現金和短期投資 | 122.807 | 209.786 | 315.067 | 154.666 | 51.66 |
現金等價物 | 34.315 | 65.799 | 34.605 | 154.666 | 51.66 |
預付的費用 | 4.899 | 5.917 | 4.487 | 1.048 | 0.024 |
總資産 | 156.255 | 247.682 | 329.67 | 158.295 | 51.826 |
物業/廠房/設備,總計 - 淨額 | 27.381 | 30.74 | 8.787 | 0.164 | 0.134 |
物業/廠房/設備,總計 - 總額 | 28.131 | 31.109 | 8.951 | 0.276 | 0.234 |
累計折舊,總計 | -0.75 | -0.369 | -0.164 | -0.112 | -0.1 |
其他長期資産,總計 | 1.168 | 1.239 | 1.329 | 2.417 | 0.008 |
流動負債總額 | 15.261 | 23.642 | 14.218 | 4.863 | 2.575 |
應付賬款 | 1.877 | 4.107 | 2.538 | 1.964 | 0.416 |
預提費用 | 13.384 | 19.535 | 11.68 | 2.899 | 0.452 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0 | 1.707 | |||
負債總額 | 40.56 | 51.782 | 21.912 | 4.879 | 6.598 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 25.299 | 28.14 | 7.694 | 0.016 | 4.023 |
總權益 | 115.695 | 195.9 | 307.758 | 153.416 | 45.228 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 60.77 | ||
普通股 | 0.005 | 0.005 | 0.005 | 0.001 | 0.001 |
額外實收資本 | 452.503 | 440.129 | 425.363 | 3.812 | 0.169 |
留存收益(累計赤字) | -334.989 | -243.82 | -118.224 | -50.97 | -15.712 |
總負債和股東權益 | 156.255 | 247.682 | 329.67 | 158.295 | 51.826 |
已發行普通股總數 | 36.4343 | 36.2346 | 36.0784 | 32.6364 | 32.6364 |
Redeemable Preferred Stock | 0 | 0 | 200.573 | ||
短期投資 | 88.492 | 143.987 | 280.462 | ||
其他權益,總計 | -0.414 | 0.614 | |||
Unrealized Gain (Loss) | -1.824 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 147.049 | 92.992 | 107.977 | 127.706 | 150.978 |
現金和短期投資 | 144.256 | 89.527 | 103.366 | 122.807 | 144.181 |
現金等價物 | 57.978 | 41.888 | 39.141 | 34.315 | 53.96 |
短期投資 | 86.278 | 47.639 | 64.225 | 88.492 | 90.221 |
預付的費用 | 2.793 | 3.465 | 4.611 | 4.899 | 6.797 |
總資産 | 172.382 | 119.879 | 135.582 | 156.255 | 180.416 |
物業/廠房/設備,總計 - 淨額 | 24.514 | 25.659 | 26.437 | 27.381 | 28.27 |
物業/廠房/設備,總計 - 總額 | 25.252 | 26.618 | 27.282 | 28.131 | 28.98 |
累計折舊,總計 | -0.738 | -0.959 | -0.845 | -0.75 | -0.71 |
其他長期資産,總計 | 0.819 | 1.228 | 1.168 | 1.168 | 1.168 |
流動負債總額 | 15.066 | 13.898 | 12.847 | 15.261 | 21.143 |
應付賬款 | 0.694 | 2.737 | 3.046 | 1.877 | 5.76 |
預提費用 | 14.372 | 11.161 | 9.801 | 13.384 | 15.383 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
負債總額 | 38.065 | 37.68 | 37.392 | 40.56 | 47.185 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 22.999 | 23.782 | 24.545 | 25.299 | 26.042 |
總權益 | 134.317 | 82.199 | 98.19 | 115.695 | 133.231 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
普通股 | 0.007 | 0.005 | 0.005 | 0.005 | 0.005 |
額外實收資本 | 532.697 | 457.871 | 455.225 | 452.503 | 449.625 |
留存收益(累計赤字) | -398.023 | -375.016 | -355.864 | -334.989 | -313.911 |
其他權益,總計 | -0.364 | -0.661 | -1.176 | -1.824 | -2.488 |
總負債和股東權益 | 172.382 | 119.879 | 135.582 | 156.255 | 180.416 |
已發行普通股總數 | 51.6352 | 36.5335 | 36.512 | 36.4343 | 36.3662 |
Redeemable Preferred Stock |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
经营活动产生的现金 | -85.082 | -100.148 | -52.146 | -24.674 | -8.454 |
经营活动产生的现金 | 0.508 | 0.205 | 0.052 | 0.047 | 0.044 |
非现金物品 | 15.48 | 18.223 | 10.014 | 10.074 | 0.079 |
营运资金的变化 | -9.901 | 7.02 | 5.042 | 0.463 | 0.354 |
投资活动产生的现金 | 53.366 | 130.613 | -281.691 | -0.021 | -0.076 |
资本支出 | -0.192 | -2.71 | -0.142 | -0.021 | -0.076 |
其他投资现金流量项目,总计 | 53.558 | 133.323 | -281.549 | 0 | |
融资活动产生的现金 | 0.177 | 0.729 | 214.944 | 127.756 | 52.312 |
融资现金流项目 | 0 | -1.743 | 0 | ||
股票的发行(报废),净额 | 0.177 | 0.729 | 214.944 | 129.499 | 52.312 |
债务的发行(退还),净额 | 0 | ||||
现金净变化 | -31.539 | 31.194 | -118.893 | 103.061 | 43.782 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -20.875 | -91.169 | -70.091 | -48.437 | -25.507 |
Cash From Operating Activities | -20.031 | -85.082 | -63.143 | -46.667 | -28.6 |
Cash From Operating Activities | 0.122 | 0.508 | 0.382 | 0.253 | 0.125 |
Non-Cash Items | 3.507 | 15.48 | 11.804 | 8.366 | 4.293 |
Changes in Working Capital | -2.785 | -9.901 | -5.238 | -6.849 | -7.511 |
Cash From Investing Activities | 24.806 | 53.366 | 51.044 | 36.537 | 16.729 |
Capital Expenditures | 0 | -0.192 | -0.192 | -0.2 | -0.007 |
Other Investing Cash Flow Items, Total | 24.806 | 53.558 | 51.236 | 36.737 | 16.736 |
Cash From Financing Activities | 0.051 | 0.177 | 0.205 | 0.153 | 0.153 |
Issuance (Retirement) of Stock, Net | 0.051 | 0.177 | 0.205 | 0.153 | 0.153 |
Net Change in Cash | 4.826 | -31.539 | -11.894 | -9.977 | -11.718 |
投資者名稱 | 投資者類型 | 流通股百分比 | 持有股份 | 股份變動 | 持有日期 | 換手率 |
---|---|---|---|---|---|---|
Bellevue Asset Management AG | Investment Advisor | 16.5502 | 8535839 | 400000 | 2023-10-17 | LOW |
Versant Ventures | Venture Capital | 12.5047 | 6449348 | 0 | 2023-03-15 | LOW |
New Enterprise Associates (NEA) | Venture Capital | 8.6257 | 4448757 | 1000000 | 2023-06-30 | LOW |
RA Capital Management, LP | Hedge Fund | 6.8361 | 3525754 | 935850 | 2023-06-30 | LOW |
Invus Public Equities Advisors, LLC | Investment Advisor | 3.968 | 2046517 | 400000 | 2023-06-30 | MED |
Boxer Capital, L.L.C. | Hedge Fund | 3.9066 | 2014858 | 0 | 2023-06-30 | LOW |
Point72 Asset Management, L.P. | Hedge Fund | 3.8778 | 2000000 | 2000000 | 2023-06-30 | HIGH |
Deerfield Management Company, L.P. | Hedge Fund | 3.49 | 1800000 | 1800000 | 2023-06-30 | MED |
RTW Investments L.P. | Investment Advisor/Hedge Fund | 3.2961 | 1700000 | 1700000 | 2023-06-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.8723 | 1481385 | 723800 | 2023-06-30 | LOW |
Citadel Advisors LLC | Hedge Fund | 2.3566 | 1215408 | 657637 | 2023-06-30 | LOW |
J.P. Morgan Securities LLC | Research Firm | 2.0931 | 1079507 | 1079507 | 2023-06-30 | MED |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 1.8323 | 945039 | 761641 | 2023-06-30 | LOW |
Epstein (David M) | Individual Investor | 1.7712 | 913479 | -25000 | 2023-06-27 | LOW |
Ally Bridge Group NY LLC | Hedge Fund | 1.5511 | 800000 | 800000 | 2023-06-30 | HIGH |
Kennedy Capital Management, Inc. | Investment Advisor | 1.4569 | 751403 | 751403 | 2023-06-30 | MED |
Heights Capital Management, Inc. | Investment Advisor | 1.4542 | 750000 | 750000 | 2023-06-30 | HIGH |
Cowen Investment Management LLC | Investment Advisor/Hedge Fund | 1.4542 | 750000 | 750000 | 2023-06-30 | HIGH |
Driehaus Capital Management, LLC | Investment Advisor/Hedge Fund | 1.3514 | 696969 | 685952 | 2023-06-30 | MED |
Rock Springs Capital Management LP | Hedge Fund | 1.0921 | 563233 | 563233 | 2023-06-30 | LOW |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Black Diamond Therapeutics, Inc. Company profile
关于 Black Diamond Therapeutics Inc
Black Diamond Therapeutics, Inc.是一家精准肿瘤医学公司。 该公司专注于发现和开发小分子、MasterKey疗法。 它建立了一个小分子激酶抑制剂的管道,针对癌症中的一系列驱动突变。 其技术平台--突变-异质-药理学(MAP)平台旨在使其能够分析群体层面的基因测序数据,以发现促进各种肿瘤类型癌症的致癌突变。 其主要候选产品BDTX-189被设计为一种口服的、不可逆的小分子抑制剂,针对ErbB激酶表皮生长因子受体(EGFR)和HER2的48种非经典和经典驱动突变。 BDTX-1535是一种脑渗透抑制剂,针对一系列的EGFR突变,包括异生和典型突变。 它还有一些早期项目,如B-拉夫原癌基因(BRAF)和成纤维细胞生长因子受体(FGFR)。
Industry: | Bio Therapeutic Drugs |
One Main Street, 14th Floor
CAMBRIDGE
MASSACHUSETTS 02142
US
收入報表
- Annual
- Quarterly
人們也觀看
还在找一位您可以信任的经纪商吗?
加入成为全球580,000万多名交易者的一份子,选择利用Capital.com进行交易吧。